Literature DB >> 21520472

Evaluation of Turkish seaweeds for antiprotozoal, antimycobacterial and cytotoxic activities.

Sevda Süzgeç-Selçuk1, Ali H Meriçli, Kasım C Güven, Marcel Kaiser, Rosalyn Casey, Suzie Hingley-Wilson, Ajit Lalvani, Deniz Tasdemir.   

Abstract

As part of our continuing research on seaweeds, crude MeOH extracts of two green, three brown and six red algae collected from Marmara, Black, Aegean and Mediterranean Seas were screened. Four parasitic protozoa, i.e. Plasmodium falciparum, Trypanosoma brucei rhodesiense, T. cruzi, Leishmania donovani and the tubercle bacillus Mycobacterium tuberculosis were used as test organisms for the in vitro assays. The selective toxicity of the extracts was also determined against mammalian L6 cells. All seaweed extracts were active against T. brucei rhodesiense; the Dasya pedicellata extract was the most potent (IC(50) value 0.37 µg/mL). The same extract also weakly inhibited the growth of T. cruzi (IC(50) 62.02 µg/mL). All seaweed extracts also showed leishmanicidal activity (IC(50) values 16.76-69.98 µg/mL). The majority of the extracts also exhibited antiplasmodial potential and the most potent extracts were those from D. pedicellata (IC(50) 0.38 µg/mL), Codium bursa (IC(50) 1.38 µg/mL) and Caulerpa rasemosa (IC(50) 3.12 µg/mL). One brown and two red algal extracts showed some weak activity against Mycobacterium tuberculosis (MIC values 125-256 µg/mL). Except for the extract of Dasya pedicellata, none of the extracts displayed any cytotoxicity. This is the second study investigating the antiprotozoal activities of Turkish marine algae and identifies Dasya pedicellata, an understudied algal species, as a candidate for further studies.
Copyright © 2010 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21520472     DOI: 10.1002/ptr.3330

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  6 in total

1.  Dolabelladienetriol, a compound from Dictyota pfaffii algae, inhibits the infection by Leishmania amazonensis.

Authors:  Deivid Costa Soares; Teresa C Calegari-Silva; Ulisses G Lopes; Valéria L Teixeira; Izabel C N de Palmer Paixão; Claudio Cirne-Santos; Dumith Chequer Bou-Habib; Elvira M Saraiva
Journal:  PLoS Negl Trop Dis       Date:  2012-09-06

2.  Assessment of dual life stage antiplasmodial activity of british seaweeds.

Authors:  Jasmine Spavieri; Andrea Allmendinger; Marcel Kaiser; Maurice Ayamba Itoe; Gerald Blunden; Maria M Mota; Deniz Tasdemir
Journal:  Mar Drugs       Date:  2013-10-22       Impact factor: 5.118

3.  Bioactive Potential of Marine Macroalgae from the Central Red Sea (Saudi Arabia) Assessed by High-Throughput Imaging-Based Phenotypic Profiling.

Authors:  Stephan Kremb; Constanze Müller; Philippe Schmitt-Kopplin; Christian R Voolstra
Journal:  Mar Drugs       Date:  2017-03-20       Impact factor: 5.118

4.  Evaluation of macroalgae sulfated polysaccharides on the Leishmania (L.) amazonensis promastigote.

Authors:  Camila Lehnhardt Pires; Selma Dzimidas Rodrigues; Daniel Bristot; Henrique Hessel Gaeta; Daniela de Oliveira Toyama; Wladimir Ronald Lobo Farias; Marcos Hikari Toyama
Journal:  Mar Drugs       Date:  2013-03-20       Impact factor: 5.118

5.  The Brown Alga Stypopodium zonale (Dictyotaceae): A Potential Source of Anti-Leishmania Drugs.

Authors:  Deivid Costa Soares; Marcella Macedo Szlachta; Valéria Laneuville Teixeira; Angelica Ribeiro Soares; Elvira Maria Saraiva
Journal:  Mar Drugs       Date:  2016-09-08       Impact factor: 5.118

Review 6.  Marine Algae as Source of Novel Antileishmanial Drugs: A Review.

Authors:  Lauve Rachel Tchokouaha Yamthe; Regina Appiah-Opong; Patrick Valere Tsouh Fokou; Nole Tsabang; Fabrice Fekam Boyom; Alexander Kwadwo Nyarko; Michael David Wilson
Journal:  Mar Drugs       Date:  2017-10-29       Impact factor: 5.118

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.